Goldman Sachs Drop Coverage of Fulcrum Therapeutics Inc. (NASDAQ: FULC).The analyst comments "We have suspended our investment rating, price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments